FDA approves GSK’s Penmenvy, a 5-in-1 meningococcal vaccine for adolescents and young adults, targeting five major serogroups of Neisseria meningitidis that cause invasive meningococcal disease.
FDA approves GSK’s Penmenvy, a 5-in-1 meningococcal vaccine for adolescents and young adults, targeting five major serogroups of Neisseria meningitidis that cause invasive meningococcal disease.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A comprehensive review published in JACI reveals how emerging diagnostic tools like the basophil activation test could reduce reliance on oral food challenges while improving accuracy for the 10% of people affected by food allergies.
Researchers find persistent weekly use of multiple disinfectants and cleaning products over 10 years shows potential association with increased asthma risk, though study notes significant uncertainty in findings.